Literature DB >> 15832081

High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases.

Hind Nassar1, Jorge Albores-Saavedra, David S Klimstra.   

Abstract

We describe the clinical and pathologic features of 14 cases of high-grade neuroendocrine carcinoma (HGNEC) of the ampulla of Vater classified according to WHO classification of lung tumors into small cell carcinoma (SCC, 6 cases) and large cell neuroendocrine carcinoma (LCNEC, 8 cases) types. The immunohistochemical findings were compared with those of 13 cases of primary poorly differentiated ampullary adenocarcinomas (PDACA) lacking neuroendocrine morphology. The mean age of 10 males and 4 females was 70 years. The mean tumor size was 2.5 cm. Ten of 13 patients had lymph node metastases (mean, 2.3 nodes involved). Documented sites of distant metastases included brain and liver. Overall, 64% of patients with ampullary HGNEC died of disease (mean follow-up, 14.5 months). Four patients had no evidence of disease after resection (mean, 20 months). Half of the tumors were associated with adenomas of the adjacent mucosa, 2 with high-grade dysplasia. Two HGNECs were combined with a conventional adenocarcinoma and another with a squamous cell carcinoma component. By immunohistochemistry, the HGNECs were positive for cytokeratins (AE1/AE3, 100%; Cam5.2, 67%; CK7, 87%; CK20, 38%), similar to the pattern found in PDACAs. p27 expression was lost in 1 case of HGNEC and in all PDACAs. Retinoblastoma (Rb) protein expression was lost in 60% of HGNECs and in none of the PDACA cases. In conclusion, HGNECs of the ampulla are rare (2%-3% of ampullary tumors in our material). The clinical course parallels that of their pulmonary counterparts and appears to be worse than that of locally advanced ampullary adenocarcinomas. The association with adenoma and or conventional adenocarcinoma components may suggest a common pathway in the initial carcinogenesis of these two types of tumors. Loss of Rb expression, a characteristic finding in pulmonary SCCs, is present in almost half of ampullary HGNECs. In contrast, p27 expression is lost in PDACAs and retained in most HGNECs. Thus, there are differences in the molecular phenotypes of these two types of ampullary carcinoma, supporting the distinction of poorly differentiated carcinomas with a neuroendocrine phenotype from those without.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832081     DOI: 10.1097/01.pas.0000157974.05397.4f

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  34 in total

1.  Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.

Authors:  Shinichi Yachida; Efsevia Vakiani; Catherine M White; Yi Zhong; Tyler Saunders; Richard Morgan; Roeland F de Wilde; Anirban Maitra; Jessica Hicks; Angelo M Demarzo; Chanjuan Shi; Rajni Sharma; Daniel Laheru; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Ralph H Hruban; Laura H Tang; David S Klimstra; Christine A Iacobuzio-Donahue
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

2.  Brain metastasis and herniation in a patient with ampullary adenocarcinoma presenting with jaundice and memory loss: case report.

Authors:  Abdullah Saleh ALQattan; Omar Ali Al-Ghamdi; Mumtaz Sarang; Mohammed Saad Al-Qahtani
Journal:  J Gastrointest Oncol       Date:  2018-10

3.  Neuroendocrine liver metastasis in gastric mixed adenoneuroendocrine carcinoma with trilineage cell differentiation: a case report.

Authors:  Wenjin Zhang; Weihua Xiao; Haifen Ma; Mingfei Sun; Hongtan Chen; Shusen Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.

Authors:  Olca Basturk; Laura Tang; Ralph H Hruban; Volkan Adsay; Zhaohai Yang; Alyssa M Krasinskas; Efsevia Vakiani; Stefano La Rosa; Kee-Taek Jang; Wendy L Frankel; Xiuli Liu; Lizhi Zhang; Thomas J Giordano; Andrew M Bellizzi; Jey-Hsin Chen; Chanjuan Shi; Peter Allen; Diane L Reidy; Christopher L Wolfgang; Burcu Saka; Neda Rezaee; Vikram Deshpande; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

5.  Ampullary neuroendocrine tumor diagnosed by endoscopic papillectomy in previously confirmed ampullary adenoma.

Authors:  Seoung Ho Lee; Tae Hoon Lee; Si-Hyong Jang; Chi Young Choi; Won Myung Lee; Ji Hey Min; Hyun Deuk Cho; Sang-Heum Park
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

6.  Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.

Authors:  Brian R Untch; Keisha P Bonner; Kevin K Roggin; Diane Reidy-Lagunes; David S Klimstra; Mark A Schattner; Yuman Fong; Peter J Allen; Michael I D'Angelica; Ronald P DeMatteo; William R Jarnagin; T Peter Kingham; Laura H Tang
Journal:  J Gastrointest Surg       Date:  2014-01-22       Impact factor: 3.452

7.  Bone and brain metastases from ampullary adenocarcinoma.

Authors:  Ioannis A Voutsadakis; Stergios Doumas; Konstantinos Tsapakidis; Maria Papagianni; Christos N Papandreou
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

8.  Coexistence of small cell neuroendocrine carcinoma and villous adenoma in the ampulla of Vater.

Authors:  Ji-Hong Sun; Ming Chao; Shi-Zheng Zhang; Guang-Qiang Zhang; Bin Li; Jian-Jun Wu
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

9.  A simplified prognostic system for resected pancreatic neuroendocrine neoplasms.

Authors:  Nikiforos Ballian; Agnes G Loeffler; Victoria Rajamanickam; Peter A Norstedt; Sharon M Weber; Clifford S Cho
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

10.  Periampullary mass--a rare presentation of poorly differentiated neuroendocrine cancer of duodenum in a young adult: a case report and review of literature.

Authors:  Neha Singh; Hemanta K Nayak; Avishek Bagchi; Premashis Kar
Journal:  BMJ Case Rep       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.